HipSci Lines: Highly Characterised Human Induced Pluripotent Stem Cells

150+ cell lines derived from phenotypically healthy donors as part of the Human Pluripotent Stem Cell Initiative (HipSci) www.hipsci.org

Technology

  • 150+ cell lines derived from phenotypically healthy donors as part of the Human Pluripotent Stem Cell Initiative (HipSci: www.hipsci.org).
  • Characterisation includes genotyping arrays, expression arrays, methylation arrays, RNA-seq, Exome-seq, proteomic mass-specrometry, whole genome sequencing, and high content cellular phenotyping.
  • HipSci founders are global leaders in the stem cell and genomics fields.
  • The Wellcome Sanger Institute is offering non-exclusive licenses on these cell lines.

Advantages

Offers you complete confidence in the background of your cell lines allowing for easy screening for genetic variants.

  • HipSci lines are highly characterised with genomic, proteomic, and phenotypic data.
  • Characterisation data is open access and freely available.
  • Donor consent expressly allows for commercial exploitation.

Applications/Context

Potential applications include:

  • Development of platforms for drug screening.
  • Disease modelling.
  • Research in regenerative medicine technologies.

 
See full index

Publications

Loading publications...

Contact

If you need help or have any queries, please contact us using the details below.